Durbin PLC
INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization
Chiesi UK and Ireland supports NHS workforce to address COPD diagnosis backlog
An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease
NICE recommends axunio’s Axhidrox cream for adults with severe hyperhydrosis
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life
Number of women in England receiving HRT on the NHS more than doubles
A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21
Achieving launch excellence through cross-functional collaboration
‘Cross-functional collaboration that’s grounded in a clear evidence roadmap is the foundation for successful, sustainable launches’
Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands
Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...
Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo
This is the first approved treatment option in the UK for patients with non-segmental vitiligo
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
Uniphar announces US expansion and company integration
The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales
New National Commission launched to strengthen AI regulation
The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance